Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Focus On Better Management, Deployment Of Existing, New Drugs Instead Of Cost

The Hill: New approach needed in fight against deadly diseases Roger Bate, scholar at the American Enterprise Institute “…Constant focus on drug pricing and criticism of lack of access can discourage developers from investing in new treatments. … TB and malaria are being combated in poor countries, but drug resistance…

Partnerships Can Help Women With Fistula Access Treatment, Care

Huffington Post: We Can Prevent and Treat Obstetric Fistula. Let’s Do Both. Catherine Murphy, director of digital marketing for Mercy Ships “On International Day to End Obstetric Fistula, the global health community paused to stand with the more than two million women around the world who live with the untreated…

U.S. Group Challenges Gilead’s Hepatitis C Drug Patents In 5 Countries

Reuters: Gilead patents on costly hepatitis C drug challenged in five countries “A U.S. group is trying to block patents in five countries for Gilead Sciences Inc.’s costly hepatitis C drug Sovaldi, in a bid to give almost 60 million afflicted people access to cheaper generic versions. In Argentina, Brazil,…

Pharmaceutical Companies Should Play Primary Role In Developing New Antibiotics

Financial Times: Big Pharma must lose its resistance to antibiotic research Anjana Ahuja, science commentator “…[T]he [U.K.’s Review on Antimicrobial Resistance] report’s unwritten message: that the curtain must come down on pure profiteering. The industry is being prompted to remember what corporate social responsibility stands for: a duty to shareholders…